← Back to Search

Proactive E-consults for COPD in HIV/AIDS Patients (ACHIEVE Trial)

N/A
Waitlist Available
Led By Christian D. Helfrich, PhD, MPH
Research Sponsored by Seattle Institute for Biomedical and Clinical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Patients: Significant cognitive dysfunction, language barriers or severe psychiatric disorder, impairing ability to participate in surveys and interviews.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline: prior to intervention roll-out. follow-up: after exposure to intervention (defined as having received at least 2 e-consults), up to 3 years.
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at an intervention to get HIV+ patients better, evidence-based care for COPD. The intervention makes it so that specialist support primary care providers who manage HIV+ patients. This way, better care can be given in real-time to patients.

Who is the study for?
This trial is for HIV+ patients with Chronic Obstructive Pulmonary Disease (COPD) who are treated by outpatient infectious disease providers at one of the seven local sites in this study. It excludes those with significant cognitive dysfunction, language barriers, or severe psychiatric disorders that impair survey and interview participation.
What is being tested?
The study tests a proactive E-consult system where pulmonologists give real-time, tailored advice to infectious disease physicians managing HIV+ patients with COPD. This aims to improve care quality without relying on traditional referrals.
What are the potential side effects?
Since this trial involves an e-consult intervention rather than medication or invasive procedures, typical medical side effects are not expected. However, there may be indirect effects related to changes in patient management.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have severe mental health issues that would prevent me from understanding or participating in surveys and interviews.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline: prior to intervention roll-out. follow-up: after exposure to intervention (defined as having received at least 2 e-consults), up to 3 years.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline: prior to intervention roll-out. follow-up: after exposure to intervention (defined as having received at least 2 e-consults), up to 3 years. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
% of COPD care recommendations received by patients of enrolled providers
Secondary study objectives
Patient health-related quality of life
Other study objectives
HIV provider satisfaction with specialty-care support

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Proactive E-consultExperimental Treatment1 Intervention
Providers in this arm will receive proactive E-consults with expert recommendations for COPD care prior to appointments with HIV+ patients with COPD.
Group II: Usual careActive Control1 Intervention
Providers in this arm will provide usual care to their HIV+ patients with COPD.

Find a Location

Who is running the clinical trial?

VA Puget Sound Health Care SystemFED
65 Previous Clinical Trials
224,535 Total Patients Enrolled
Washington D.C. Veterans Affairs Medical CenterFED
42 Previous Clinical Trials
17,598 Total Patients Enrolled
VA Eastern Colorado Health Care SystemFED
54 Previous Clinical Trials
25,948 Total Patients Enrolled

Media Library

Proactive E-consult Clinical Trial Eligibility Overview. Trial Name: NCT03856879 — N/A
Chronic Obstructive Pulmonary Disease Research Study Groups: Proactive E-consult, Usual care
Chronic Obstructive Pulmonary Disease Clinical Trial 2023: Proactive E-consult Highlights & Side Effects. Trial Name: NCT03856879 — N/A
Proactive E-consult 2023 Treatment Timeline for Medical Study. Trial Name: NCT03856879 — N/A
~42 spots leftby Oct 2025